rheumatology
Bone health

Long-term alendronate fracture fears allayed

The bisphosphonate alendronate has an acceptable balance between benefit and risk in terms of fracture outcomes, even for over 10 years of continuous use, new research concludes. Writing in a study in The BMJ the Danish authors said previous research had highlighted concerns that antiresorptive treatment could lead to atypical femur fractures that could offset ...

Already a member?

Login to keep reading.


OR
© 2021 the limbic